Hanny Al-Samkari, M.D.

Job Title: 
Associate Director, MGH HHT Center
Treatments or Procedures Provided: 
Bevacizumab IV
Iron Therapy IV
Other AVM Treatment
Conditions Treated: 
Intestinal bleeding
Intestinal telangiectasia
Nasal AVM
Other AVM
Language Spoken: 
Ages Treated: 
Adults (18 years or older)
55 Fruit St.
Boston, MA 02215
United States
Scheduling Contact
(617) 726-8748
Education & Facts
Board Certification: 
American Board of Internal Medicine
Residency Program:
Hospital of the University of Pennsylvania - 2014
Dr. Al-Samkari is Associate Director of the Massachusetts General Hospital HHT Center of Excellence. He is a hematologist who specializes in bleeding and clotting disorders, with a specific focus in bleeding disorders and HHT. In addition to management of bleeding, he specializes in management of anemia associated with HHT, typically due to severe and often refractory iron deficiency. He has seen and treated over a hundred patients with HHT with bleeding and/or anemia. He is a recognized leader in investigation and clinical treatment of the treatment of HHT with anti-angiogenic therapies, including bevacizumab (Avastin).
55 Fruit St.
Boston, MA 02215
United States
Last Updated: September 16, 2019
Go to top